CPT Code 17266: Malignant lesion destruction (4.0+ cm)

Key takeaways

CPT Code 17266 describes destruction of a malignant skin lesion on the trunk, arms, or legs with a lesion diameter greater than 4.0 cm.

All five destruction methods (laser surgery, electrosurgery, cryosurgery, chemosurgery, and surgical curettement) are equally valid for billing 17266.

Medicare coverage requires documented confirmation of malignancy, a measured lesion diameter exceeding 4.0 cm, and the anatomic site recorded in the operative note.

Pabau’s claims management software helps dermatology practices automate CPT code submission, attach supporting documentation, and track claim status from a single workflow.

CPT Code 17266 reports destruction of a malignant skin lesion on the trunk, arms, or legs. The lesion diameter must exceed 4.0 cm, and any of five destruction methods qualifies. It sits at the top of the trunk/arms/legs destruction ladder, so its documentation bar is correspondingly high.

Payers expect pathology confirmation or a clear clinical malignancy determination, a precise measurement, and the anatomic site in the operative note before they release payment.

This reference guide covers the official descriptor, the 17260-17266 code series, ICD-10-CM crosswalk codes, and 2026 Medicare payment rates. It also covers RVU data, documentation requirements, and the billing rules that most frequently trigger denials for this code.

CPT Code 17266: Official descriptor and code details

The American Medical Association (AMA) maintains the CPT code set and defines the official descriptor for 17266. It reads: Destruction, malignant lesion (e.g., laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), trunk, arms or legs; lesion diameter over 4.0 cm.

It falls under the “Destruction Procedures on Malignant Lesions” section of the Surgery chapter. All five destruction modalities in the descriptor carry equal billing validity. Selecting the right code depends on the anatomic site and the measured lesion diameter, not on the technique the provider used.

The quick-reference table below captures the key attributes coders need at a glance.

Destruction methods covered under this code

The CPT descriptor for 17266 uses “e.g.” before listing the five modalities, which is significant. It signals that the listed methods are examples, not an exhaustive requirement. In practice, however, these five modalities cover virtually every technique used clinically for malignant lesion destruction.

Coders do not need to modify the code based on which method was used. The method belongs in the operative note, not in the code selection.

• Laser surgery: Uses focused light energy to ablate tissue. Commonly used for superficial malignancies and lesions where thermal precision reduces surrounding tissue damage.
• Electrosurgery: Applies electrical current to destroy tissue. Often used in curettage-and-desiccation (C&D) protocols for basal cell carcinoma on the trunk.
• Cryosurgery: Liquid nitrogen or nitrous oxide freezes and destroys malignant tissue. For a lesion over 4.0 cm, multiple freeze-thaw cycles and careful margin tracking are typical. See Pabau’s guidance on structured medical documentation for recording freeze-thaw cycles consistently.
• Chemosurgery (Mohs technique): Applies a chemical fixative before staged excision and histologic examination. When Mohs surgery is performed, specific Mohs codes apply; plain chemosurgery references in 17266 typically describe older escharotic techniques.
• Surgical curettement: Mechanical scraping of the tumor bed. Often combined with electrodesiccation and reported as a single procedure.

Each method is billing-equivalent under 17266. Payer policies do not distinguish between modalities for reimbursement purposes under this code; the size threshold and anatomic location are the determining factors.

CPT Code 17266 in the malignant lesion destruction series

Codes 17260 through 17266 form a size-based ladder for malignant lesion destruction on the trunk, arms, or legs. Each step up the ladder corresponds to a larger lesion diameter range.

Selecting the wrong code in this series is one of the most common reasons claims for this procedure category are downcoded or denied during audit. The table below maps each code to its diameter range, and CPT 17264 covers the size band directly below 17266.

Note that there is no 17265 in this series. The ladder jumps from 17264 (3.1-4.0 cm) directly to 17266 (over 4.0 cm). A lesion measured at exactly 4.0 cm bills under 17264, not 17266. The documented diameter must exceed 4.0 cm for 17266 to apply.

For related billing codes for allied health services, Pabau also maintains guides for other CPT code sets, including CPT 17380 for electrolysis epilation.

ICD-10-CM codes commonly used with CPT 17266

Every CPT 17266 claim needs a supporting ICD-10-CM diagnosis code that confirms the malignant nature of the lesion. According to CMS ICD-10-CM guidance, payers require a specific malignancy code rather than a symptom or “rule-out” code.

The C44 series (other malignant neoplasms of skin) covers the majority of cases billed under 17266. Consistent recording of the site and histology in the patient record is essential across specialties. Pabau’s guide to medical chart audits covers this kind of detail.

Always code to the highest level of specificity available. If pathology has confirmed basal cell carcinoma on the trunk, C44.519 is more appropriate than C44.509. Crosswalk tools such as the AAPC CPT-to-ICD-10 crosswalk can assist with confirming pairing accuracy for 17266.

Medicare reimbursement and fee schedule for CPT Code 17266

Medicare covers 17266 under the Medicare Physician Fee Schedule (MPFS), published annually by CMS. Reimbursement varies by geographic locality, but CMS publishes national payment amounts as a baseline.

The figures below reflect approximate 2026 national rates. Verify current amounts using the CMS MPFS lookup tool before billing, since rates update each January.

These are approximate national figures sourced from published fee schedule data. Actual reimbursement depends on geographic adjustment (GPCI), the provider’s participation status, and any applicable modifiers. Always verify against the current CMS MPFS before submitting claims.

RVU breakdown for CPT 17266

Relative Value Units determine how Medicare calculates payment. The three components are Work RVU (physician time and intensity), Practice Expense RVU (overhead costs), and Malpractice RVU (liability insurance).

The table below shows approximate component values; confirm exact figures using the PCC free 2026 RVU calculator before revenue modeling.

Documentation requirements for billing 17266

CMS Billing and Coding Article A57638, associated with LCD L33813, outlines the documentation standards for malignant lesion destruction codes. Meeting these requirements before claim submission is what separates a clean first-pass approval from a Records Development Letter or outright denial.

The requirements are more specific for a lesion over 4.0 cm than for smaller codes in the series. Auditors know larger lesions are higher-value claims, so they scrutinize them more closely.

• Confirmed malignancy: Pathology report confirming malignancy is the gold standard. Where a biopsy was not performed pre-destruction, the operative note must include a clear clinical diagnosis of malignancy based on examination findings. Document the reasoning.
• Measured lesion diameter greater than 4.0 cm: The exact measurement must appear in the medical record. “Large lesion” or “lesion over 4 cm” without a precise figure is insufficient for audit defense.
• Anatomic site: Document trunk, upper extremity (arm), or lower extremity (leg) specifically. “Back” clarifies trunk. “Left forearm” clarifies upper limb.
• Destruction method used: Record which method was applied (cryosurgery, electrosurgery, etc.) in the operative or procedure note.
• Pre- and post-procedure notes: Document the clinical indication, informed consent, and post-procedure care instructions. Digital forms can automate pre-procedure consent capture and link it directly to the patient encounter.
• Pathology submission (where applicable): If tissue was sent for analysis, the pathology report number should be referenced in the encounter note.

Practices using skin clinic software with built-in procedure note templates can standardize this documentation checklist across all providers, reducing the variation that triggers audit flags.

For a broader view of how coding documentation connects to claim outcomes, see the other CPT code reference guides in the Pabau procedure codes library.

Billing guidelines and common mistakes

Dermatology billing for malignant lesion codes has a well-documented pattern of errors. Practices that see high denial rates for the 17260-17266 series are usually making one of a small number of recurring mistakes. Addressing these systematically through billing workflow design prevents the same errors from compounding across hundreds of claims.

Multiple lesions billed in the same session

When multiple malignant lesions are destroyed in the same session, CPT guidelines allow reporting each lesion separately. Bill the highest-value code first, then each additional lesion individually with modifier 59 (distinct procedural service) to indicate separate lesions.

Do not bundle multiple lesions into a single 17266 claim unless the clinical record accurately reflects a single contiguous lesion exceeding 4.0 cm. Line-item claim building supports accurate billing for multi-lesion encounters.

Modifier use and when it applies

Modifier 59 (or XS, XE, XP, XU when applicable) is used to distinguish separate anatomic sites or separate lesions in the same encounter. Modifier 51 (multiple procedures) applies when 17266 is billed alongside another surgical procedure, subject to the multiple-procedure reduction rules.

Modifier 25 does not apply here, since 17266 is a surgical procedure, not an E&M service. Always verify modifier requirements with the specific payer, since some Medicare Administrative Contractors (MACs) have local modifier policies that override national guidance.

Common denial reasons

• Missing or imprecise lesion diameter: Documented as “about 4 cm” rather than “>4.0 cm” or a specific measurement such as “4.3 cm.” Auditors downcode to 17264 if measurement is ambiguous.
• Malignancy not confirmed: Claim submitted before pathology report returned, with no clinical malignancy rationale in the encounter note.
• Wrong anatomic site group: A lesion on the scalp, neck, face, or genitalia requires a different code series (17270-17286). Submitting 17266 for a scalp lesion is an incorrect code selection regardless of size.
• Unbundling with excision codes: If a lesion is excised (11600-11646 series) rather than destroyed, the excision codes apply. Destruction and excision are not interchangeable. Billing both for the same lesion is a bundling error.
• Missing ICD-10-CM specificity: Submitting a symptom code or a benign lesion code (D22 series) instead of a confirmed malignancy code (C44 series).

How Pabau supports dermatology billing

Accurate billing for codes like 17266 depends on documentation quality at the point of care. When the clinician’s note and the biller’s submission don’t match, that mismatch is where most dermatology revenue leaks occur.

Pabau’s claims management software connects the clinical encounter directly to the claim. The procedure code, ICD-10-CM pairing, and supporting documentation travel together through the billing workflow.

Dermatology EMR software like Pabau’s connects documentation directly to claim submission for practices handling high-volume lesion destruction cases. Practices billing complex wound care alongside lesion destruction can also reference Pabau’s guide to CPT 15276 for skin substitute graft applications.

Key billing workflow capabilities relevant to 17266 include the following.

• Procedure note templates that prompt clinicians to enter lesion diameter and anatomic site before signing.
• Automatic ICD-10-CM pairing suggestions based on the entered diagnosis.
• Real-time claim status tracking.

Digital forms capture pre-procedure consent and post-procedure care documentation, keeping the full clinical record audit-ready from day one.

Streamline dermatology billing from documentation to claim submission

Pabau helps dermatology and skin clinic teams attach procedure notes, ICD-10 codes, and consent forms directly to each patient encounter. Claims then move through a connected billing workflow without manual re-entry.

Book a demo

Conclusion

CPT Code 17266 is the highest-value code in the trunk/arms/legs malignant destruction series, and it draws proportionally more scrutiny from payers. The two failure points that account for most denials are missing lesion diameter specificity and absent malignancy confirmation. Both come down to documentation completed at the point of care.

Pabau’s procedure note templates and patient record management workflows help dermatology teams capture these details at the point of care. Nothing gets left out before the claim is submitted. To see how Pabau handles dermatology billing documentation end to end, book a demo.

Continue your research

Need to know when excision replaces destruction coding? CPT Code 19125 covers breast lesion excision billing, a useful comparison point against the destruction codes in this guide.

Want procedure notes captured without extra typing? 7 best AI medical scribe tools compares tools that capture lesion measurements and site details at the point of care.

Frequently asked questions